#LiverCancerAwarenessMonth

Author: Turacoz Group
October 23, 2015

Liver cancer: Treatment

Liver cancer treatment is generally based on the stage of disease and the patient response to treatment. Treatment is individualized as each patient respond differently. Based on the disease stage, the size, number, tumor location, other co-morbidities, overall health and well-being, the treatment is decided. Based on the complexity of the tumor a team of specialists are associated in the treatment. The team involves surgeons, oncologists, radiologists, gastroenterologists, radiation therapists, and pathologists.

Liver cancer is generally identified in patients who come to the hospitals with damaged livers. Also as the liver cancer stage increases the side effects also may become worse. Therefore, in order to be safe, best options to treat liver cancer should be chosen.

Treatment options

  • The best treatment option is to remove the liver surgically but only <10% of the patients are suitable for surgery. The reasons can be due to cirrhosis (due to bleeding, infection or liver failure), more tumors that are widespread to remove all. Even after successful surgery, there are some tiny deposits of tumors which are not even visible for the scans or surgery. The survival rate of patients having the surgery is >5 years.
  • Other option when there is no evidence of the spread of liver cancer includes liver transplantation. This method involves transplantation of a diseased liver with a healthy liver from a donor. Recent advances in transplantation techniques and immune medications have made transplantation the first choice for patients with cirrhosis and small tumors. The survival rate is >70% with >5 years.
  • Other possible options include injecting the liver with a toxic material such as pure alcohol or chemotherapy in order to destroy it, cryotherapy, radiofrequency ablation etc. These techniques are used in patients with only one or two small tumors, in general.
  • Chemoembolization which involves chemotherapy drugs which can be given directly into the blood vessel that feeds the liver and the tumors. This technique requires a hospital admission, and can cause pain, fever, nausea, and liver damage.
  • Radioembolization or selective internal radiation therapy (SIRT) which is almost similar to chemoembolization in which microscopic radioactive particles are used instead of chemotherapy injected into the blood vessels. This is as effective as chemoembolization for small and multiple tumors.
  • Radiation therapy which uses high-dose energy like X-rays aimed at a small part of the body and can frequently destroy cancer cells. In some cases other techniques like conformal or stereotactic radiation may be useful.

Liver cancer: outcomes

The best treatment options of all discussed above includes surgery and transplantation. Physicians with the help of several tests and scans determines the turmors. Although local treatments such as radiofrequency ablation, cryoablation, and chemoembolization can kill tumors that are visible, “new” tumors may develop which are invisible to the scan or tests. Also, the cirrhosis and conditions that gave rise to the initial cancers will still be there even after successful treatment, so more cancers might actually develop later.

Liver cancer: Prevention

For treating cancers, it not only depends on the type of treatment but also on financial strength. With the growing costs of the machines and drugs one should be able to overcome these. These kind of situations not effect at personal level of the patient.

Hepatoma can be a preventable disease. Hepatitis, alcohol abuse, and obesity can be avoided through

  • Social
  • Medical
  • Lifestyle changes

Also with this transition, there are some chances of improvement observed in the survival rates of liver cancer and hence there is a cause for optimisim.

Liver cancer: Prognosis

The outcome of hepatoma is extremely variable and depends as much upon the state of the liver and the person’s health as on any characteristic of the cancer itself. Therapies such as radiofrequency ablation, chemoembolization, cryoablation, radiosurgery, radioembolization, and systemic therapy are frequently performed sequentially over a patient’s lifetime, depending upon the changes as the disease progresses. Average survival for patients who are able to be treated with these methods is between one and two years.

Multiple techniques can be used in the extension of a patient’s life, while keeping them well and happy. Many drugs have been introduced for the treatment recognizing the molecular defects causing the cancer and few others are still under research. The evolution and improvement in radiologic and interventional technology has helped millions of people in prolongation of their lives. Also the survival rates was almost doubled since early 1990s. Increased and improved medical, scientific, and pharmaceutical areas helped to gain more attention for this disease and still make a better future.

Health tips:

  • Maintain a healthy weight
  • Regular exercise
  • Avoid fad diets (weight loss plans)
  • Limit in the intake of fat
  • Moderate alcohol consumption
  • Regular liver check-ups
  • Quit smoking
  • Be aware of drug risks
  • Vaccinations for hepatitis B

Turacoz Healthcare Solutions as a socially responsible company spreads the word and awareness and looks forward to collaboration or associations with other agencies/companies with similar goals and aspirations. We have a skilled and competent team of medical writers, clinicians, researchers and biostatisticians. Our clients include major pharmaceutical companies, hospitals and healthcare professionals. Our experience has been in supporting publications, creating regulatory documents, conducting observational studies, designing and creating for print and digital marketing as well as customizing sessions on medical writing. 

Tags: , , , , , , ,

You Might Also Like

  • Top Benefits of Using Academic Research Writing Services

    “Write the paper as though no editor will ever see it … then let a good editor make sure everyone

  • World Thyroid Day 2025: How AI Is Revolutionizing Thyroid Health

    World Thyroid Day invites us to appreciate the tiny, butterfly-shaped gland with a big job in managing our body’s energy,

  • How AI is redefining content creation in pharma — And why humans are still the drivers of trust

    In an era where speed, efficiency, and personalization have become imperatives, Artificial Intelligence (AI) — particularly machine learning, AI algorithms,

  • World Thalassemia Day 2025: Giving a Voice to the Global Patient Community

    Every 8 May, World Thalassemia Day shines an international spotlight on the millions of people living with this inherited genetic disorder.

  • Decoding Ovarian Cancer Symptoms: Communicating the Silent Signs

    Ovarian cancer remains one of the most challenging gynaecologic malignancies, often referred to as a “silent killer” due to its subtle onset and late-stage diagnosis.1 In 2022, 324,603 women worldwide were diagnosed with ovarian cancer.

  • 4 Ways in Which HEOR is Transforming Healthcare with RWE

    The healthcare landscape is being reshaped at an unprecedented pace, powered by sophisticated data analytics, emerging technologies, and the escalating

  • The Role of HEOR in Payer Decisions to Switch from Originators to Biosimilars

    Biosimilars—biologic medicines that are highly similar to FDA-approved originator biologics—offer a cost-effective alternative without compromising clinical efficacy.1,2 Since the first

  • Content’s Industrial Revolution: Shaping the Future of Pharma

    Communications In a rapidly evolving digital ecosystem, the pharmaceutical industry’s relationship with content is undergoing a seismic shift. At the

  • Health Journalism: Combating Misinformation with Accuracy

    By Turacoz Healthcare Solutions | World Liver Day 2025 In a world where social media dominates wellness discussions, liver health

  • Patient Voices Matter: How Patient-reported Outcomes Are Redefining Market Access

    The healthcare industry is experiencing a paradigm shift as patient voices take center stage in drug development and approval processes.

Newsletter

Stay informed with the latest trends, insights, and updates in medical communications—download our newsletter now.

partner with us

Partner with Turacoz to bring science to life through strategic and evidence-based communication.

Partner with Us